Professor Anthony Chalmers and Co-Investigator Dr Natividad Gomez-Roman have further developed a 3D human cell culture model replacing the use of mice to evaluate and screen treatments for Glioblastoma (GBM).
605 results
Principal Investigator: Dr Carina Dunlop, University of Surrey
Principal Investigator: Dr Pierre-Alexis Mouthuy, University of Oxford
Principal Investigator: Dr Richard van Arkel, Imperial College London
Principal Investigator: Dr Gowsihan Poologasundarampillai, University of Birmingham
Principal Investigator: Dr Peter Rugg-Gunn, Babraham Institute Cambridge
Principal Investigator: Dr Inés Cebola, Imperial College London
Principal Investigator: Dr Anna Krasnodembskaya, Queen's University Belfast
Principal Investigator: Dr Michael Colman, University of Leeds
Principal Investigator: Dr Gabriel Galea, University College London
Current contact: Dr Ellen Forty,
Professor Cathy Merry has developed synthetic hydrogels that support 3D culture for multiple cell types and used NC3Rs funding to support their application across multiple scientific disciplines.
Dr Karl Butterworth and PhD Student Dr Kathryn Brown have applied high precision cancer radiotherapy techniques used to treat human patients to improve the reproducibility and translatability of preclinical animal trials.
Dr Paola Campagnolo has used NC3Rs funding from a Project grant and a Skills and Knowledge Transfer award to develop an ex vivo model of the epicardium to replace the use of mice for high throughput screening of cardiac therapies in academia and industry.
Principal Investigator: Professor Robert Hindges, King's College London
Principal Investigator: Professor Manuel Mayr, Imperial College London
Principal Investigator: Professor Amir Ghaemmaghami, University of Nottingham
Principal Investigator: Professor Stephanie Dakin, University of Oxford
Principal Investigator: Professor Jennifer Rohn, University College London
Principal Investigator: Dr Lee Borthwick, Newcastle University
